Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

Clinical trial NCT07175662 · RECRUITING

Trial details

NCT number: NCT07175662
Sponsor: Newish Biotech (Wuxi) Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-grade Squamous Intraepithelial Lesion (HSIL)

Start date: 2025-11-11
Primary completion: 2027-05-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.